What is Ibrutinib?
Feb 10,2020



References
- Related articles
- Related Qustion
- BTK inhibitor Ibrutinib:Brand names,Uses,Dietary instructions and Toxicity Jul 30, 2025
Ibrutinib is a small molecule with the ability to form a covalent bond with Cys-481 in the ATP binding domain of BTK. The IC50 of ibrutinib for BTK is 0.5 nM.
- Immunosuppressant Ibrutinib:Indications, Class and Drug interactions Mar 25, 2025
Ibrutinib is a first-in-class, potent, orally administered covalently-binding inhibitor of BTK, it may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
- Ibrutinib: Uses, Mechanism of action and Side effects Apr 2, 2024
Ibrutinib is an oral, potent, selective and irreversible small molecule inhibitor of Btk. It is a prescription drug with the trade name IMBRUVICA?.
Linagliptin (TrajentaR, TradjentaTM, TrazentaTM, TrayentaTM) is an oral, highly selective inhibitor of dipeptidyl peptidase-4 and is the first agent of its class to be eliminated predominantly via a nonrenal route.....
Feb 10,2020DrugsDocetaxel (Taxotere?), a cytotoxic taxane, is an antimicrotubule agent effective in the treatment of patients with breast cancer.....
Feb 10,2020DrugsIbrutinib
936563-96-1You may like
- Ibrutinib
-
- $1.00 / 1g
- 2025-08-05
- CAS:936563-96-1
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 100kg
- Ibrutinib
-
- $0.00 / 10g
- 2025-08-05
- CAS:936563-96-1
- Min. Order: 1g
- Purity: 99% HPLC
- Supply Ability: 10000
- Ibrutinib
-
- $5.00/ KG
- 2025-08-05
- CAS:936563-96-1
- Min. Order: 1KG
- Purity: 99% hplc
- Supply Ability: 500TONS